Concepedia

Emily Pace

EP

4

Publications

428

Citations

4

H-Index

2006

Active since

Affiliations

Merrimack Pharmaceuticals (United States)(Current)

Emily Pace is an author at Merrimack Pharmaceuticals (United States) specializing in cell biology, medicine, and tumor microenvironment.

Top concepts

Publications per year

2006–2017

4

Publications

4

An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation

Birgit Schoeberl, Anthony C. Faber, Danan Li et al. · Cancer Research · 2010 · 260 citations · Full text

, , +18

Computational Modeling of <i>ERBB2</i> -Amplified Breast Cancer Identifies Combined ErbB2/3 Blockade as Superior to the Combination of MEK and AKT Inhibitors

Daniel C. Kirouac, Jin Du, Johanna Lahdenranta et al. · Science Signaling · 2013 · 107 citations

Predicting ligand-dependent tumors from multi-dimensional signaling features

Helge Hass, Kristina Masson, Sibylle Wohlgemuth et al. · npj Systems Biology and Applications · 2017 · 49 citations · Full text

A Data-Driven Computational Model of the ErbB Receptor Signaling Network

Birgit Schoeberl, Emily Pace, Shavonne Howard et al. · 2006 · 12 citations

, , +18

Rows per page

1–4 of 4